Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00700726 · ClinicalTrials.gov registry record
Cohort Study of the Patterns of Microvesicles in the Serum of Participants With Atopic and Non-atopic Asthma
A clinical trial, sponsored by Ohio State University.
- Completed
- Registry status
- 26
- Enrollment target
NCT00700726: Completed study, sponsored by Ohio State University.
NCT00700726 is a clinical trial that has completed, run by Ohio State University. The registered enrollment target is 26 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00700726 has completed, sponsored by Ohio State University.
- COMPLETED
- Registry status
- 26 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if a simple blood test can help in disease management, particularly asthma. This will be researched by looking at certain features of the blood and to compare asthmatics without allergies to those that have allergy-induced asthma.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2008-06 |
| Est. Completion | 2013-12 |
What the finished NCT00700726 record still lists
NCT00700726 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 26 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00700726 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00700726 about?
NCT00700726 is a clinical study titled "Cohort Study of the Patterns of Microvesicles in the Serum of Participants With Atopic and Non-atopic Asthma". The purpose of this study is to determine if a simple blood test can help in disease management, particularly asthma. This will be researched by looking at certain features of the blood and to compare asthmatics without allergies to those that have allergy-induced asthma.
What is the current status of trial NCT00700726?
This trial is currently completed. The enrollment target is 26 participants. The study started on 2008-06. Estimated completion is 2013-12.
Who is sponsoring clinical trial NCT00700726?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02646475 · 26 participants · Phase 1
Metabolic Effects of Angiotensin-(1-7)
- NCT03603223 · 26 participants · Phase 2
Pembrolizumab in Treating Participants With Leukoplakia
- NCT04063592 · 26 participants · NA
AMI Construction in Lower Extremity Residual Limbs
- NCT04906460 · 26 participants · Phase 1
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia